Serina Therapeutics
SER
59 hedge funds and large institutions have $24.8M invested in Serina Therapeutics in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
32% more capital invested
Capital invested by funds: $18.7M → $24.8M (+$6.01M)
13% more funds holding
Funds holding: 52 → 59 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 0.49% → 0.48% (-0%)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Price Capital Management
Lafayette,
Louisiana
|
+$182K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$142K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$134K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$76.8K |
| 5 |
DWM
Destination Wealth Management
Walnut Creek,
California
|
+$74.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$429K |
| 2 |
State Street
Boston,
Massachusetts
|
-$155K |
| 3 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$120K |
| 4 |
BlackRock
New York
|
-$82.3K |
| 5 |
Jane Street
New York
|
-$70K |
SER Hedge Fund Activity: Q1 2019 in Review
59 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2019, worth a combined $24.8M — up 32% from $18.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new SER positions and 5 closed out — a net gain of 7 holders — while 13 added to existing stakes and 16 trimmed.
The largest buyer was Price Capital Management, adding an estimated $182K. The largest seller was State of Wisconsin Investment Board, cutting an estimated $429K.
- 59 institutional investors held Serina Therapeutics (SER) as of Q1 2019, up from 52 in Q4 2018.
- Funds reported $24.8M of Serina Therapeutics stock for Q1 2019, up 32% quarter-over-quarter.
- 12 funds opened new Serina Therapeutics positions in Q1 2019 and 5 closed out, a net change of +7 holders.
- The largest Serina Therapeutics buyer in Q1 2019 was Price Capital Management, an estimated $182K added.
- The largest Serina Therapeutics seller in Q1 2019 was State of Wisconsin Investment Board, an estimated $429K sold.
Based on aggregated 13F filings for Q1 2019.